Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Reliable Cervical Cancer Screening

Based on available study data, GynTect® provides a clear indication of malignancy status in patients with abnormal Pap smear: In all previous studies, GynTect was able to detect all cancer cases of the cervix (Sensitivity = 100%).

GynTect is rarely positive in cytological normal patients (Specificity = 96.6%). Cancer occurs via the histopathology defined dysplasia CIN1, CIN2 and CIN3. GynTect detection rates for this dysplasia increase continuously. This indicates a prognostic value of the GynTect cancer marker.

Download to find out more.


Go Top